FDA authorizes Pfizer's booster shots for high-risk populations

Name: FDA authorizes Pfizer's booster shots for high-risk populations
Uploaded: 2021-09-23T10:21:00Z
Duration: 1 min 54 s
Description: The U.S. Food and Drug Administration agreed with a government advisory panel and approved the Pfizer-BioNTech COVID-19 vaccine booster for those who are 65 years and older or run a high risk of severe disease.

The U.S. Food and Drug Administration agreed with a government advisory panel and approved the Pfizer-BioNTech COVID-19 vaccine booster for those who are 65 years and older or run a high risk of severe disease.

Posted September 23, 2021 6:21am EDT